Home>Congress>New super PAC attacks Hugin on price of cancer drugs

Republican U.S. Senate candidate Bob Hugin

New super PAC attacks Hugin on price of cancer drugs

Roginsky serves as executive director of Leadership Alliance New Jersey

By David Wildstein, August 14 2018 9:01 am

A new super PAC with ties to a powerful New Jersey Democrat will begin airing a new TV ad today attacking Republican U.S. Senate candidate Hugin for earning millions by gouging cancer patients with an expensive-life saving drug.

The group, Leadership Alliance New Jersey, will air the ad on North Jersey cable systems, backed up by a “substantial six-figure buy.”

Leadership Alliance New Jersey is being run by Julie Roginsky, a powerhouse political strategist and consultant wrote the campaign plan that got Phil Murphy the Democratic gubernatorial nomination in 2017.

“Big Pharma Bob Hugin is spending the $100 million he earned gouging desperate cancer patients to buy himself a senate seat, so that he can go to Washington and further Donald Trump’s radical agenda,” said Roginsky. “At a time when cancer patients were forced to spend $700 dollars on a pill that cost Hugin less than one dollar to produce, Hugin hired DC lobbyists to fight against those who wanted to make this life-saving medication more affordable. Just imagine the damage he would do to New Jerseyans as a United States senator.”

 

 

Leadership Alliance | Title: “Get Rich” | TV :30 s | August 2018
Video:
Image: Bob Hugin.
Image: Book/Story graphic treatment.
ALT: Hard Copy News story graphic treatment.(Image Relay: Visuals of Hugin’s lavish lifestyle, including yacht, multiple homes and ski lodge.)CG: Bob Hugin, Chairman & CEO of CelgeneImage: Bottle of Revlimid.
CG: List Price: $700 dollars per pill, $20,000 per month.

Image: FDA Names drugmakers potentially acting to delay cheaper, generics.

Image: “Hugin earned himself $100 million in just three years…”
CG: One Hundred Million Dollars

Image: Republican Hugin spending millions to compete in New Jersey

CG: Bob Hugin spends $15.5 million on senate campaign.

CG: It’s up to you how this story ends.

Paid for by Leadership Alliance,leadershipalliancenj.com, not authorized by any candidate or candidate’s committee.  Leadership Alliance is responsible for the content of this advertising.

Audio:
How did Bob Hugin build a lavish lifestyle off the backs of cancer patients?Step one: Take control of a giant pharmaceutical company.Step two: Charge $700 per pill for a critical cancer drug that only takes 65 cents to make.
[Drugs.com, Revlimid Prices][Twitter, “Today’s Drug Prices”, Meg Tirrell] [Bloomberg, The Loopholes Drug Companies Use to Keep Prices High, 12.20.17]Step three: Pay DC lobbyists millions to stop cheaper, life-saving versions of the cancer drug

[Kaiser Health News, Drugmakers Dramatically Boosted Lobbying Spending In Trump’s First Quarter
,4.21.17]
[Bloomberg, A Drug Program That Keeps Patients Safe (And Profits, Too), 7.26.17]

Step four: Pocket more than one hundred million dollars
[NJ, Is Menendez’s Republican challenger even more ethically challenged?, 3.418]

His next step?  Use that money from cancer patients to buy a Senate Seat?

VO: Leadership Alliance is responsible for the content of this advertising.

Back-up:
On June 16, 2010, Bob Hugin became CEO of Celgene.  Source: http://ir.celgene.com/releasedetail.cfm?releaseid=799385
As of 7/9/18, 100 capsules of Revlimid cost $69,547.81. Source: [Drugs.com, Revlimid Prices][Twitter, “Today’s Drug Prices”, Meg Tirrell]
On 12/20/17, Bloomberg reported that “a year’s worth of 10-milligram Revlimid doses costs about $240 to produce.” Source: https://www.bloomberg.com/news/features/2017-12-20/the-loopholes-drug-companies-use-to-keep-prices-highIn 2017-2018, Celgene spent $4.64 million on lobbying. Sources:https://www.opensecrets.org/lobby/clientsum.php?id=D000032432&year=2018Celgene’s lobbyists work on the company’s behalf to delay cheaper generic drugs from coming to market. 
Sources: [Bloomberg, A Drug Program That Keeps Patients Safe (And Profits, Too), 7.26.17]
[Reuters, FDA names drugmakers potentially acting to delay cheap generics
5
.17.18]https://www.nj.com/opinion/index.ssf/2018/02/did_hugins_company_celgene_endanger_cancer_patient.htmlHugin has earned $100 million in salary, benefits, stock, and stock options from Celgene. ($48 million in salary and benefits in 2017, $22.5 million in 2016, $22.47 million in salary in 2015; $24.24 million in salary in 2014.) https://efdsearch.senate.gov/search/print/paper/d321b4c6-dfd6-486b-a6a2-3377ee013b93/
https://www.fiercepharma.com/pharma/celgene-chief-hugin-nabs-22m-for-his-ceo-swan-song
https://www.fiercepharma.com/special-report/top-20-highest-paid-biopharma-ceos
https://www.biospace.com/article/5-highest-paid-biopharma-ceos-of-2016-/

Hugin has put $15.5 million of his own money into his 2018 campaign for U.S. Senate. [WTOP, Republican Hugin spending millions to compete in New Jersey, 7.21.18]

###

 

Spread the news:

One thought on “New super PAC attacks Hugin on price of cancer drugs

Leave a Reply

Your email address will not be published. Required fields are marked *